iNOS

Inducible nitric oxide synthase (iNOS), along with neuronal nitric oxide synthase (nNOS) and endothelial nitric oxide synthase (eNOS), catalyze the generation of nitric oxide and L-citrulline from L-arginine and molecular oxygen. It displays high affinity for Ca2+/calmodulin.

Products
Background
Gene Data

iNOS Inhibitors

Cat. No. Product Name / Activity
0871 AMT hydrochloride
Potent, selective iNOS inhibitor
0546 L-NIO dihydrochloride
NOS inhibitor
1415 1400W dihydrochloride
Potent, highly selective iNOS inhibitor

Inducible nitric oxide synthase (iNOS), along with neuronal nitric oxide synthase (nNOS) and endothelial nitric oxide synthase (eNOS), catalyze the generation of nitric oxide and L-citrulline from L-arginine and molecular oxygen. It displays high affinity for Ca2+/calmodulin, thus appears to be constitutively active. Tetrahydrobiopterin, flavin adenine dinucleotide, flavin mononucleotide and NADPH co-factors are required for catalytic activity.

iNOS gene expression is regulated by various pathways including NF-κB, IFN-γ (signaling through the JAK-STAT cascade) and HIF-1, which induce expression, and TGF-β and interleukins -4, -10 and -13, which inhibit expression. Post-translational regulation occurs by prevention of iNOS homodimerization by NAP110.

iNOS has roles in the innate immune system and displays antibacterial, antiviral and antifungal activity. The human gene encoding iNOS is localized to chromosome 17q11.2-q12.

External sources of pharmacological information for iNOS :

    iNOS Gene Data

    Species Gene Symbol Gene Accession No. Protein Accession No.
    Human NOS2 NM_000625 P35228
    Mouse Nos2 NM_010927 P29477
    Rat Nos2 NM_012611 Q6XS76